Epidemiology of nosocomial fungal infection in the 1990s

Revista Iberoamericana de Micologia

Volumn 15, Issue 1, 1998, Pages 2-6

  Trick, William Edmund ^a   Jarvis, William Robert ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002130870     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Voss A, Kluytmans JA, Koeleman JG, et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996; 15-909-912
2. Chakrabarti A, Ghosh A, Batra R, Kaushal A, Roy P, Singh H. Antifungal susceptibility pattern of non-albicans Candida species and distribution of species isolated from candidaemia cases over a 5 year period. Indian J Med Res 1996; 104:171-176
3. Chen YC, Chang SC, Sun CC, Yang LS, Hsieh WC, Luh KT. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 1997; 18:369-375.
4. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991: 91:86S-89S.
5. Vargas SL, Thompson L. Current status and future prospects for medical mycology in a developing country. Int J infect Dis 1997;1:S2-S6.
6. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995, 20: 1526-1530.
7. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989; 149:2349-2353.
8. Pannuti CS, Gingrich RD, Pfaller MA, Wenzel RP. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J Clin Oncol 1991; 9:77-84
9. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6:428-442.
10. Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR. Risk factors for candidemia in patients with acute lymphocyte leukemia. Rev Infect Dis 1991;13:211-215.
11. Karabinis A, Hill C, Leclerq B, Tancrede C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 1988; 26:429-432.
12. Vazquez JA, Sanchez V, Dmuchowski C, Dembry L, Sobel JD, Zervos MJ Nosocomial acquisition of Candida albicans: An epidemiologic study J Infect Dis 1993, 168:195-201
13. CDC. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996. issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996, 24:380-388.
14. Fridkin SK, Welbel SF, Weinstein RA. Magnitude and prevention of nosocomial infections in the intensive care unit Infect Dis Clin North Am 1997, 11:479-496.
15. Rangel-Frausto MS, Houston AK, Bale MJ, Fu C, Wenzel RP. An experimental model for study of Candida survival and transmission in human volunteers Eur J Clin Microbiol Infect Dis 1994; 13:590-595.
16. Clemons KV, Feroze F, Holmberg K, Stevens DA. Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods J Clin Microbiol 1997; 35:1332-1336.
17. Hughes WT. Systemic candidiasis: a study of 109 fatal cases Pediatr Infect Dis 1982;1:11-18
18. Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diag Microbiol Infect Dis 1993: 17:103-109.
19. De Bernardis F, Girmenia C, Boccanera M, Adriani D, Martino P, Cassone A Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating manno-protein of Candida spp. in neutropenic patients with invasive candidiasis. J Clin Microbiol 1993; 31:3142-3146
20. McNeill MM, Gerber AR, McLaughlin DW, et al. Mannan antigenemia during invasive candidiasis caused by Candida tropicalis. Pediatr Infect Dis J 1992: 11 :493-496.
21. Walsh TJ, Chanock SJ Laboratory diagnosis of invasive candidiasis': A rationale for complementary use of culture- and nonculture-based detection systems. Int J Infect Dis 1997; 1:S11-S19
22. Obayashi T, Yoshida M, Mori T, et al. Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345:17-20.
23. Chryssanthou E, Andersson B, Petrini B, Lofdahl S, Tollemar J. Detection of Candida albicans DNA in serum by polymerase chain reaction. Scand J Infect Dis 1994; 26:479-485
24. Maenza JR, Keruly JC, Moore RD, Chaisson RE, Merz WG, Gallant JE. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients J Infect Dis 1996; 173:219-225
25. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis J Antimicrob Chemother 1995, 35:103-114.
26. Dube MP, Heseltine PN, Rinaldi MG, Evans S, Zawacki B. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis 1994; 18:77-82.
27. Chandrasekar PH, Gatny CM. The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. J Antimicrob Chemother 1994; 33:309-318
28. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation N Engl J Med 1992: 326:845-851.
29. Stavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study. J Infect Dis 1995; 171:1545-1552.
30. Borg-von ZM, Eiffert H, Kann M, Ruchel R. Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Gottingen, Germany. Mycoses 1993; 36:247-253.
31. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325:1274-1277.
32. Girmenia C, Martino P, De Bernardis F, et al Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis 1996; 23:506-514.
33. Weems JJJr, Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 1987; 25:1029-1032.
34. Solomon SL, Alexander H, Eley JW, et al Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr Infect Dis 1986; 5:680-685.
35. Greaves I, Kane K, Richards NT, Elliott TS, Adu D, Michael J. Pigeons and peritonitis? Nephrol Dial Transplant 1992; 7:967-969
36. Waggoner-Fountain LA, Walker MW, Hollis RJ, et al Vertical and horizontal transmission of unique Candida species to premature newborns. Clin Infect Dis 1996; 22:803-808.
37. Welbel SF, McNeil MM, Kuykendall RJ, et al. Candida parapsilosis bloodstream infections in neonatal intensive care unit patients' epidemiologic and laboratory confirmation of a common source outbreak. Pediatr Infect Dis J 1996, 15:998-1002.
38. Vazquez JA, Boikov D, Boikov SG, Dajani AS Use of electrophoretic karyotyping in the evaluation of Candida infections in a neonatal intensive-care unit. Infect Control Hosp Epidemiol 1997; 18:32-37
39. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 32:452-456.
40. Strausbaugh LJ, Sewell DL, Ward TT, Pfaller MA, Heitzman T, Tjoelker R. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol 1994; 32:2299-2300
41. Sanchez V, Vazquez JA, Barth-Jones D, Dembry L, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med 1993; 94:577-582
42. Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob Agents Chemo 1995; 39:40-44
43. Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP. Systemic candidiasis in cancer patients. Am J Med 1984, 77:20-27.
44. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemo 1993; 37:1847-1849.
45. Zhang J, Hollis RJ, Pfaller MA. Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis. Diag Microbiol Infect Dis 1997; 27:63-67.
46. Finkelstein R, Reinhertz G, Hashman N, Merzbach D Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit. Infect Control Hosp Epidemiol 1993; 14:537-590.
47. Isenberg HD, Tucci V, Cintron F, Singer C, Weinstein GS, Tyras DH. Single-source out-break of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 1989; 27:2426-2428.
48. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995, 20:115-125
49. Berrouane YF, Hollis RJ, Pfaller MA Strain variation among and antifungal susceptibilities of isolates of Candida krusei. J Clin Microbiol 1996; 34:1856-1858.
50. Wald A, Leisenring W, van Bunk JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175:1459-1466.
51. Aisner J, Wiernik PH, Schimpft SC. Treatment of invasive aspergillosis' relation of early diagnosis and treatment to response. Ann Int Med 1977; 86:539-543.
52. Andriole VT Aspergillus infections, problems in diagnosis and treatment. Infect Agents Dis 1996; 5:47-54.
53. Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections J Clin Microbiol 1995, 33:2913-2919
54. Einsele H, Hebart H, Roller G, et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997; 35:1353-1360.
55. Trigg ME, Morgan D, Burns TL, et al Successful program to prevent Aspergillus infections in children undergoing marrow transplantation, use of nasal amphotericin. Bone Marrow Transplantation 1997, 19:43-47.
56. Tablan OC, Anderson LJ, Arden NH, Breiman RF, Butler JC, McNeil MM. Guideline for prevention of nosocomial pneumonia The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol 1994, 15:587-627.
57. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996, 33:23-32.
58. Weems JJJr, Davis BJ, Tablan OC, Kaufman L, Martone WJ. Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infection Control 1987, 8:71-75.
59. Mahoney DHJ, Steuber CP, Starling KA, Barrett FF, Goldberg J, Fernbach DJ. An outbreak of aspergillosis in children with acute leukemia. J Pediatr 1979; 95:70-72.
60. Arnow PM, Sadigh M, Costas C, Weil D, Chudy R. Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms. J Infect Dis 1991 ; 164:998-1002.
61. Gerson SL, Parker P, Jacobs MR, Creger R, Lazarus HM. Aspergillosis due to carpet contamination. Infect Control Hosp Epidemtol 1994; 15:221-223.
62. Arnow PM, Andersen RL, Mainous PD, Smith EJ. Pulmonary aspergillosis during hospital renovation. Am Rev Resp Dis 1978; 118:49-53.
63. Mitchell SJ, Gray J, Morgan ME, Hocking MD, Durbin GM. Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet 1996; 348:441-443.
64. Orth B, Frei R, Itin PH, et al. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Int Med 1996, 125:799-806.
65. Fridkin SK, Kremer FB, Bland LA, Padhye A, McNeil MM, Jarvis WR. Acremonium kiliense endophthalmitis that occurred after cataract extraction in an ambulatory surgical center and was traced to an environmental reservoir. Clin Infect Dis 1996; 22:222-227.
66. Stephenson J. Investigators seeking new ways to stem rising tide of resistant fungi. JAMA 1997; 277:5-6.
67. Okhuysen PC, Rex JH, Kapusta M, Fife C. Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans. Clin Infect Dis 1994; 19:329-331.
68. Cohen DM, Bhalla SC, Anaissie EJ, Hester JP, Savary CA, Rex JH. Effects of in vitro and in vivo cytokine treatment, leucapheresis and irradiation on the function of human neutrophils implications for white blood cell transfusion therapy Clin Lab Haematol 1997; 19:39-47
69. Raad I Hachem R, Zermeno A, Stephens LC, Bodey GP. Silver iontophoretic catheter, a prototype of a long-term antiinfective vascular access device J Infect Dis 1996; 173:495-498
70. Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia Cancer 1984, 53.411-419
71. Spanik S, Kukuckova E, Pichna P, et al Analysis of 553 episodes of monomicrobial bacteraemia in cancer patients' any association between risk factors and outcome to particular pathogen? Supportive Care in Cancer 1997; 5:330-333.
72. George MJ, Snydman DR, Werner BG, et al The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients Am J Med 1997, 103:106-113
73. Patel R, Portela D, Badley AD, et al. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation Transplantation 1996; 62:926-934
74. Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation 1995; 59:851-859.
75. Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994; 170:644-652.
76. Morrison VA, Haake RJ, Weisdorf DJ. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med 1994; 96:497-503.
77. Dib JC, Dube MP, Kelly C, Rinaldi MG, Patterson JE. Evaluation of pulsed-field gel electrophoresis as a typing system for Candida rugosa. comparison of karyotype and restriction fragment length polymorphisms. J Clin Microbiol 1996; 34:1494-1496
78. McCray E, Rampell N, Solomon SL, Bond WW, Martone WJ. O'Day D. Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation. J Clin Microbiol 1986; 24:625-628.
79. Leeming JG, Moss HA, Elliott TS. Risk of tongue depressors to the immunocompromised. Lancet 1996; 348:889.